Hirotatsu Sato

Wakayama Medical University

Papers

1

Total Citations

2

H-Index

1

About

Hirotatsu Sato is a urological researcher whose work centers on improving prostate cancer diagnostics and surgical outcomes. His key research areas include prostate MRI interpretation, pathological staging, and the refinement of risk stratification for radical prostatectomy patients. Sato’s major contribution lies in investigating how preoperative imaging, specifically PI-RADS v2 findings, can predict pathological extraprostatic extension (EPE)—a critical factor in treatment planning. In his most-cited study (2022), he demonstrated that combining PI-RADS v2 scores with positive biopsy core percentages offers a more accurate, non-invasive method to anticipate EPE before robot-assisted radical prostatectomy. This work has garnered 2 citations and provides clinicians with practical tools to better counsel patients and tailor surgical approaches. While his citation count is modest, Sato’s research addresses a pressing clinical need: reducing the gap between imaging and pathology. His findings contribute to the growing movement toward precision medicine in urologic oncology, helping to avoid unnecessary overtreatment while ensuring oncologic safety. For students and researchers, Sato’s work exemplifies how focused, institution-based retrospective studies can yield actionable insights that directly impact surgical decision-making.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
PI-RADS v2 Findings of MRI and Positive Biopsy Core Percentage would Predict Pathological Extraprostatic Extension in Patients who Underwent Robot Assisted Radical Prostatectomy: A Retrospective Study.
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Wakayama Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago